Showing results (201-210 of 271) with videos related to

Sort By:
Pageof 28
Frontiers in Pediatrics|October 31, 2022
Caregiver distress: A mixed methods evaluation of the mental health burden of caring for children with bladder exstrophyKatelyn A Spencer, Jaishri Ramji, Pooja Unadkat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2019
Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular SchwannomaScott R Plotkin, Dan G Duda, Alona Muzikansky, et al.
Scientific Data|June 13, 2018
Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived schwann cellsMarc Ferrer, Sara J C Gosline, Marigo Stathis, et al.
American Journal of Medical Genetics. Part A|January 19, 2010
What's new in neurofibromatosis? Proceedings from the 2009 NF Conference: new frontiersJoseph L Kissil, Jaishri O Blakeley, Rosalie E Ferner, et al.
Genes, Chromosomes & Cancer|September 12, 2017
Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancerXia Wang, Jamie K Teer, Renee N Tousignant, et al.
The Lancet. Oncology|March 7, 2018
Working plan for the use of patient-reported outcome measures in adults with brain tumours: a Response Assessment in Neuro-Oncology (RANO) initiativeLinda Dirven, Terri S Armstrong, Jaishri O Blakeley, et al.
Pediatric Blood & Cancer|May 28, 2020
Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1Amy E Armstrong, Steven D Rhodes, Abbi Smith, et al.
Molecular Cancer Therapeutics|September 19, 2019
Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of Nf1-Deficient MiceCiersten A Burks, Steven D Rhodes, Waylan K Bessler, et al.
Neuro-Oncology|August 24, 2018
Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working GroupRaymond Y Huang, Wenya Linda Bi, Michael Weller, et al.
NMR in Biomedicine|April 19, 2026
Unique Peritumoral Patterns Unveiled by Quantitative Multiparametric MRI and Their Diagnostic and Prognostic Value in Treated Malignant GliomasKeyi Chai, Puyang Wang, Austin Carmichael, et al.
Pageof 28